Lung Neoplasms

Search with Google Search with Bing
Information
Disease name
Lung Neoplasms
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT04283994 Active, not recruiting N/A Project to Improve Communication About Serious Illness--Hospital Study: Comparative Effectiveness Trial (Trial 2) July 26, 2021 August 1, 2025
NCT04380636 Active, not recruiting Phase 3 Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012) July 6, 2020 February 15, 2027
NCT02871856 Active, not recruiting N/A International Lung Screen Trial (ILST) April 5, 2017 December 2025
NCT04230408 Active, not recruiting Phase 2 Intensified Chemo-immuno-radiotherapy With Durvalumab for Stage III Non-Small Cell Lung Cancers March 5, 2021 December 19, 2024
NCT03085069 Active, not recruiting Phase 2 A Study to Evaluate SHR-1210 in Patients With Advanced or Metastatic NSCLC May 3, 2017 August 20, 2023
NCT05231278 Active, not recruiting N/A Confocal Laser Endomicroscopy Nodule Localization by Robotic Bronchoscopy January 20, 2022 December 30, 2024
NCT02623712 Active, not recruiting N/A The Watch the Spot Trial March 6, 2017 July 31, 2024
NCT02514512 Active, not recruiting N/A Lung Cancer Radiotherapy Using Realtime Dynamic Multileaf Collimator (MLC) Adaptation And Radiofrequency Tracking September 2015 December 2025
NCT04862780 Active, not recruiting Phase 1/Phase 2 (SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC June 29, 2021 January 31, 2025
NCT01946100 Active, not recruiting N/A Treatment of Multifocal Lung Adenocarcinoma October 2013 October 2025
NCT01770418 Active, not recruiting Phase 1/Phase 2 A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer March 2013
NCT03705546 Active, not recruiting The Impact of Physical Activity on the Postoperative Symptoms, Complications, and Quality of Life Among Lung Cancer March 4, 2016 March 3, 2026
NCT06259461 Active, not recruiting Machine Learning to Construct an Association Model for Lung Cancer and Environmental Hormone January 1, 2023 June 30, 2024
NCT04498052 Active, not recruiting N/A Evaluation of a Scalable Decision Support and Shared Decision Making Tool for Lung Cancer Screening August 23, 2020 September 28, 2024
NCT03872362 Completed Radiomics Multifactorial Biomarker for Pulmonary Nodules July 11, 2018 February 1, 2019
NCT03922828 Completed Lung Nodule Prospective Database May 1, 2018 January 1, 2021
NCT04051827 Completed Phase 1 Drug-Drug Interaction Study of TAK-788 and Midazolam in Participants With Advanced Non-small Cell Lung Cancer (NSCLC) December 23, 2019 December 7, 2021
NCT03986463 Completed CIrculating Tumour DNA in Lung Cancer (CITaDeL): Optimizing Sensitivity and Clinical Utility May 1, 2019 December 31, 2020
NCT00123760 Completed Phase 2/Phase 3 Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer February 2004 December 2008
NCT00129844 Completed Phase 2 Study of Motexafin Gadolinium (MGd) for Second Line Treatment of Non-Small-Cell Lung Cancer September 2005 December 2007
NCT00157196 Completed Phase 2 Safety Study of Tecemotide (L-BLP25) in Non-Small Cell Lung Cancer (NSCLC) Subjects With Unresectable Stage III Disease April 2005 April 2012
NCT00157209 Completed Phase 2 Phase 2b Randomized Controlled Study of Tecemotide (L-BLP25) for Immunotherapy of NSCLC (Non-Small Cell Lung Cancer) August 2000 July 2012
NCT00174629 Completed Phase 3 GILT Docetaxel - Non-Small Cell Lung Cancer June 2001
NCT00174772 Completed Phase 2 Pulmonart: Docetaxel - Non-Small Cell Lung Cancer (NSCLC) March 2004 February 2009
NCT00178230 Completed Circulating Cytokines as Predictors of Radiation Induced Pulmonary Toxicity March 15, 1996 November 25, 2013
NCT00184275 Completed Characterization of Brain Metastases May 2005 December 2010
NCT06347965 Completed N/A Construction and Effect Evaluation of the Low Load Blood Flow Restriction Training Program for Lung Cancer Patients Complicated With Sarcopenia During Chemotherapy February 1, 2023 February 20, 2024
NCT00207298 Completed 18F-fluorodeoxyglucose (18F-FDG) Positron Emission Tomography in Oncology June 2005 August 2015
NCT00243685 Completed Phase 2/Phase 3 Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis September 2006 May 2009
NCT00258739 Completed Phase 2 Docetaxel in Non Small Cell Lung Cancer (NSCLC) October 2001
NCT00266877 Completed Phase 2 Study Evaluating the Safety Of HKI-272 (Neratinib) In Subjects With Advanced Non-Small Cell Lung Cancer December 2005 January 2009
NCT00316225 Completed Phase 2 Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen December 2006 March 2009
NCT00338481 Completed Phase 4 "Red Morphine Drops" for Symptomatic Treatment of Dyspnoea in Lung Cancer April 2006 February 2011
NCT00339859 Completed DNA Repair, p53 and Apoptosis Phenotypes in Lung Cancer June 2, 1995 May 6, 2020
NCT00351962 Completed N/A Phase I/II Study of Fractionated Stereotactic Radiotherapy for Medically Inoperable NSCLC or Metastatic Lung Tumours September 2006 July 2, 2014
NCT00001499 Completed Phase 2 Phase II Neoadjuvant Trial of a Continuous Infusion of Paclitaxel Plus Cisplatin Followed by Chest Radiotherapy for Patients With Stage III Non-Small Cell Lung Cancer March 1996 June 2000
NCT00385177 Completed Phase 1 Phase 1 Dose Escalation Study of SN2310 Injectable Emulsion in Patients With Advanced Solid Tumors September 2006 May 2009
NCT00413283 Completed Phase 2 Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC) December 2006 February 2009
NCT00482118 Completed Smoky Coal Exposure, Genetic Susceptibility, and Lung Cancer in Non-Smoking Women in China February 6, 2006 November 20, 2020
NCT00497770 Completed An Observational Study of the Ethnic Impact of Patients Undergoing Second (2nd) Line Treatment for Non-Small Cell Lung Cancer Using Pemetrexed February 2007 March 2011
NCT00534690 Completed N/A Does PEP Compensate the Reduction of Tidal Volume During One Lung Ventilation? November 2007 January 2009
NCT03220230 Completed Validation of Molecular Diagnostic Thecnologies for Lung Cancer Patients. July 6, 2015 October 30, 2018
NCT06195657 Completed Pre-operative Localization of Ground Glass Solitary Pulmonary Nodules March 2012 November 2021
NCT00563420 Completed N/A Early Lung Cancer Detection in Patients With Sputum Cytology and Autofluorescence Bronchoscopy in People at High Risk of Lung Cancer November 2002 June 2007
NCT00591981 Completed Thoracic OncoGeriatric Assessment (TOGA) Trials August 2007 August 2012
NCT00639067 Completed Breath Test for Early Detection of Lung Cancer June 2008 December 2013
NCT00805077 Completed N/A Pulmonary Surgery and Protective Mechanical Ventilation December 2008 July 2012
NCT00826852 Completed Phase 2 Weekly Docetaxel and Four Weekly Carboplatin in Non-small Cell Lung Cancer Carbo-Tax October 2003 July 2009
NCT00841191 Completed Phase 1/Phase 2 A Safety, Efficacy and Pharmacokinetic Study of Siltuximab (CNTO 328) in Participants With Solid Tumors March 2009 April 2011
NCT00925444 Completed Phase 4 Staple-line Reinforcement for Prevention of Pulmonary Air Leakage June 2009 March 2013
NCT00001805 Completed Phase 2 A Phase II Clinical Trial of Suppression of Human Antimouse Antibody and Human Antitoxin Response to Immunotoxin LMB-1 by Rituximab March 1999 June 2000
NCT00034606 Completed Phase 2 Comparing 3 Schedules of Alimta Plus Gemzar
NCT00978250 Completed Phase 2 A Multi-Histology Phase II Study of 5-Fluoro-2'-Deoxycytidine With Tetrahydrouridine (FdCyd + THU) August 20, 2009 April 11, 2019
NCT01038661 Completed Phase 3 Tax First-line Chemotherapy With Different Doses and Then Maintenance Therapy November 2009 August 2012
NCT01039649 Completed A Study to Test Lung Function After Radiation Therapy June 2009 December 2013
NCT01039948 Completed Phase 1/Phase 2 A Phase 1b/2 Study in Asian Subjects With Non-Small Cell Lung Cancer December 2009 August 2013
NCT01109524 Completed Phase 2 Safety Study of Cetuximab in Combination With Cisplatin and Vinorelbine to Treat Advanced Non-small Cell Lung Cancer July 2010 September 2012
NCT01114958 Completed Phase 1 Pilot Study of Intra-Arterial Cisplatin With IV Thiosulfate in Patients With Lung Cancer or Lung Metastases September 3, 2009 May 17, 2013
NCT01130753 Completed Phase 2 Efficacy of Erlotinib in Neoadjuvant Setting in Patients With Stage IIIA, N2-positive Non-Small Cell Lung Cancer January 2007 December 2012
NCT01218854 Completed Phase 1 A Comparison of Methods for Assisting Needle Angle Selection During Image-guided Tissue Biopsy March 20, 2012 November 16, 2016
NCT01266512 Completed Phase 2 Concurrent Chemoradiotherapy Using Intensity Modulated Radiotherapy (IMRT) & Docetaxel-cisplatin (or Carboplatin) Followed by Adjuvant Chemotherapy for Inoperable Stage III Non-small-cell Lung Cancer January 2011 March 2014
NCT01267305 Completed N/A The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic Surgery January 2011 August 2013
NCT01307085 Completed N/A Effect of Remote Ischemic Preconditioning on Lung Injury After Pulmonary Resection February 2011 June 2013
NCT01335893 Completed Phase 1 Intraoperative Imaging of Thoracic Malignancies With Indocyanine Green May 2011 December 14, 2014
NCT01370278 Completed N/A Clearance Of Mucus In Stents (COMIS) June 16, 2011 August 23, 2023
NCT01413737 Completed Postoperative Results of Surgical Treatment of Lung Cancer After 30 Days January 2002 December 2006
NCT01466660 Completed Phase 2 LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the Lung December 13, 2011 April 12, 2019
NCT00034957 Completed Phase 2 Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC) October 2002
NCT01540045 Completed Effect of Chemotherapy With Paclitaxel/Cisplatin on Development Dysgeusia in Non Small Cell Lung Cancer December 2010 May 2012
NCT00036023 Completed Phase 2 Chemotherapy Related Anemia in Patients With Non-Myeloid Malignancies
NCT01631565 Completed Phase 3 Early Incorporation of Patient and Family to Attention and Care Program in Oncology Versus Standard of Care May 2012 January 2016
NCT01658280 Completed Phase 4 Conventional Versus Ultrasound-guided Transbronchial Needle Aspiration for the Diagnosis of Hilar/Mediastinal Lymphadenopathies August 2012 July 2015
NCT00558350 Completed Systemic, Intrapulmonary and Pleural Inflammatory Reaction in Patients Undergoing Thoracic Surgery April 2007 June 2011
NCT00120939 Completed Phase 1 Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer
NCT03325907 Completed N/A Transthoracic Needle Biopsy Using 3D Printed Navigational Template: A Phase I Feasibility Trial June 1, 2020 September 3, 2020
NCT03331588 Completed Phase 3 Comparison of Post-operative Pain and Quality of Life Between Subxiphoid and Intercostal VATS for Lung Cancer November 10, 2017 February 28, 2020
NCT04313361 Completed A Study of Smoking Cessation Patterns in Participants Undergoing Lung Surgery May 6, 2020 December 9, 2021
NCT03499535 Completed N/A Impact of Smoking Information on Concerns About Radon August 7, 2015 April 22, 2016
NCT03521375 Completed N/A VIdeo Assisted Thoracoscopic Lobectomy Versus Conventional Open LobEcTomy for Lung Cancer July 2015 March 2020
NCT04264325 Completed Quantitative Diaphragmatic Ultrasound Evaluation in Pleural Effusions : A Feasability Study January 31, 2020 May 3, 2023
NCT04246125 Completed Patient Skin Dose in Interventional Radiology October 13, 2020 June 7, 2022
NCT04241315 Completed Phase 3 ELUCIDATE: Enabling Lung Cancer Identification Using Folate Receptor Targeting March 26, 2020 November 1, 2021
NCT03607539 Completed Phase 3 Efficacy and Safety Evaluation of Sintilimab in Patients With Advanced or Metastatic Non-squamous NSCLC August 23, 2018 February 13, 2023
NCT03612804 Completed N/A Promoting Smoking Cessation in Lung Cancer Screening Through Proactive Treatment May 10, 2019 February 9, 2023
NCT00123747 Completed Phase 2 Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients Receiving a Treatment Planning Study of 3 Dimensional Conformal Radiation Therapy Guided by Breath Held CT and PET Imaging for Patients With Non-Small Cell Lung Cancer August 2005 October 2008
NCT04211051 Completed N/A Safety and Feasibility of Pulmonary Surgery Marker System in the Intraoperative Localization of Small Pulmonary Nodules April 15, 2020 October 21, 2020
NCT02333474 Completed Phase 1/Phase 2 Safety and Efficacy of Mix Vaccine in Lung Carcinoma Patient January 2015 August 2015
NCT02334007 Completed Phase 1/Phase 2 Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery September 2015 September 2018
NCT02359175 Completed Phase 4 Supplementary Epidural Analgesia in Video-Assisted Thoracic Surgery (VATS) - The SEAVATS Study February 2015 March 22, 2023
NCT02370303 Completed A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System August 2014 July 9, 2016
NCT02372448 Completed N/A Multicenter Validation of the Sensitivity of Theranostic ALK Rearrangement Detection by FISH Analysis and Prevalence of Escaping Mutations in Circulating Tumor Cells for the Non-invasive Management of Lung Cancer Patients January 23, 2015 November 21, 2019
NCT02410603 Completed Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer December 2016 January 1, 2021
NCT02483052 Completed Phase 1/Phase 2 RejuvenAir Lobectomy for Safety and Histology August 2015 February 2016
NCT02500693 Completed N/A Circulating Tumor Cells in Lung Cancer Screening October 30, 2015 October 13, 2020
NCT02528942 Completed N/A Feasibility Study Incorporating Lung Function Imaging Into Radiation Therapy for Lung Cancer Patients April 22, 2016 January 25, 2021
NCT02531737 Completed Phase 2 Nintedanib (Vargatef®) Plus Docetaxel in Second Line of Treatment in Patients With Lung Cancer September 2015 September 26, 2020
NCT02540499 Completed N/A Deep Inspiration Breath Hold as Primary Strategy for Locally Advanced Lung Cancer Radiotherapy May 2015 December 2020
NCT05358158 Completed N/A Chest dRain rEmoval intrAoperatively afTer thoracOscopic Wedge Resection May 4, 2022 March 17, 2024
NCT02603016 Completed N/A Efficacy Study of Clinical Nutrition to Treat Lung Neoplasms And Breast Carcinoma November 2015 February 2017
NCT02629523 Completed Phase 2 Afatinib in Lung Cancer With EGFR Mutation From Circulating Tumor DNA June 1, 2016 May 11, 2020
NCT02650661 Completed N/A Efficacy of a Smart Management Strategy for Health (SMASH) Program for Overcoming Cancer Crisis and Growing Positively November 23, 2015 January 2018
NCT00067691 Completed N/A Acupuncture for Shortness of Breath in Cancer Patients November 2001 November 2003
NCT02674815 Completed N/A Preoperative High Intensity Interval Training: The PHIIT Trial February 2016 December 2016
NCT00001450 Completed Phase 2 Phase II Trial of a 96-Hour Continuous Infusion of Paclitaxel Followed by Cisplatin for Patients With Stage III/IV and Relapsed NSCLC September 1995 June 2000
NCT00069160 Completed Phase 2 Tariquidar and Docetaxel to Treat Patients With Lung, Ovarian, Renal and Cervical Cancer September 2003 December 2009
NCT00071136 Completed Phase 1/Phase 2 Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) December 2003 August 2006
NCT02744664 Completed Phase 4 Cryotherapy Combine Icotinib for Advanced NSCLC Treatment April 1, 2016 August 15, 2017
NCT02757092 Completed N/A The Impacts of Pulmonary Rehabilitation Therapy on Patients After Thoracic Surgery March 31, 2016 May 31, 2017
NCT02759835 Completed Phase 2 Local Ablative Therapy for Treatment of Oligoprogressive, EGFR-Mutated, Non-Small Cell Lung Cancer After Treatment With Osimertinib April 13, 2016 September 20, 2022
NCT02769286 Completed Phase 2 Osimertinib in First and Second Line Treatment of NSCLC Harboring EGFR Mutations From Circulating Tumor DNA August 2016 May 2020
NCT02790866 Completed N/A Development and Feasibility Testing of a Lung Cancer Screening Decision Aid March 2016 December 2016
NCT02793713 Completed EBUS Score Validation for Malignancy June 2016 September 17, 2017
NCT04619472 Completed N/A Safety and Effectiveness of Radiofrequency Ablation System in the Treatment of Peripheral Lung Tumors January 7, 2021 March 27, 2023
NCT00073398 Completed Phase 1/Phase 2 Vaccine Treatment for Advanced Non-Small Cell Lung Cancer November 2003 March 2013
NCT00074854 Completed Phase 1/Phase 2 A Clinical Efficacy Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 Given In Combination With Chemotherapy May 2002 March 2005
NCT02845479 Completed Phase 3 The Thoracic Peri-Operative Integrative Surgical Care Evaluation (POISE) Trial- Stage I December 7, 2018 December 7, 2020
NCT02855281 Completed Sensitivity of PDL-1-analysis From Pleural Effusion in Non-small Cell Lung Cancer October 2016 December 2018
NCT00080041 Completed Phase 1 Study of Motexafin Gadolinium and Docetaxel for Advanced Solid Tumors
NCT02872701 Completed Phase 2 OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules May 4, 2017 November 30, 2018
NCT02879773 Completed Computed Tomography Assessment of Regional Ventilation (CURVE) January 22, 2016 July 31, 2019
NCT02897778 Completed Phase 1 Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors August 24, 2016 March 13, 2017
NCT04502654 Completed Rehabilitation for Thoracoscopic Lobectomy September 15, 2020 July 21, 2021
NCT02909452 Completed Phase 1 Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors September 20, 2016 February 9, 2021
NCT02926768 Completed Phase 1 Phase I/II Study of CK-101 in NSCLC Patients and Other Advanced Solid Tumors September 2016 June 2022
NCT02958683 Completed Chest Wall Motion Analysis in Disease July 2011 July 31, 2015
NCT02962115 Completed N/A Development and Pilot Testing of a Clinical Informatics Lung Cancer Screening Intervention November 2016 March 31, 2017
NCT02965391 Completed Dynamic Changes of Circulating Tumor DNA in Surgical Lung Cancer Patients November 2016 November 2019
NCT03017183 Completed N/A Detection of Heterogeneity in Central Lung Cancer - EBUS-TBNA and ctDNA Analysis vs. Endobronchial Forceps Biopsy January 2, 2017 July 31, 2017
NCT00094094 Completed Phase 2 Anti-angiogenesis Agent AG-013736 in Patients With Advanced Non-Small Cell Lung Cancer February 2005 July 2007
NCT03059641 Completed Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy of NSCLC Patients in China February 22, 2017 January 30, 2020
NCT03077230 Completed N/A Pre-Post Study for Supporting Appropriate Implementation of Lung Cancer Screening May 2015 April 2017
NCT04419207 Completed Detecting Lung Cancer Based on Exhaled Breath March 1, 2019 January 31, 2022
NCT03134872 Completed Phase 3 A Study of SHR-1210 in Combination With Pemetrexed and Carboplatin in Subjects With Non-squamous NSCLC May 12, 2017 August 29, 2019
NCT03171636 Completed Frequency of EGFR and KRAS Mutations and Clinical-prognostic Correlation in Brazilian Lung Cancer Patients April 2014 January 2019
NCT01703351 Completed Phase 2 Prospective Randomized Trial Comparing the Effectiveness of Continuous Paravertebral Infusion of Local Anesthetics Versus Intravenous Patient-controlled Analgesia on Acute and Chronic Neuropathic Pain After VATS Lobectomy October 4, 2012 November 6, 2015
NCT01776372 Completed N/A Comparison of Pleural Drainage Systems on Reducing Pleural Effusion Formation Following Lung Resection January 2013 December 2013
NCT01793246 Completed Registry Trial to Determine pCLE Image Interpretation Criteria and Preliminary Accuracy in the Lung February 2013 December 24, 2016
NCT01928836 Completed Risk Stratification of Patients Using the Lung Cancer Biomarker Panel in China October 2012 January 2015
NCT01933789 Completed N/A Improving Communication About Serious Illness September 2013 December 2016
NCT00041808 Completed Phase 1/Phase 2 Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver July 2001 April 2003
NCT02031809 Completed Multicentric Study VATS Major Introperative Complications January 2014 October 2015
NCT02106143 Completed N/A RejuvenAir™ System Lobectomy Safety and Histology Study September 2014 October 2015
NCT00050830 Completed Phase 2 A Phase 2, Randomized, Open-Label Study Of Single Agent CI-1033 In Patients With Advanced Non-Small Cell Lung Cancer January 2003 November 2005
NCT00051506 Completed Phase 2 ALIMTA(Pemetrexed)/Cisplatin and ALIMTA(Pemetrexed)/Carboplatin in Extensive Stage Small Cell Lung Cancer.
NCT02123173 Completed Hemodynamic Changes During One Lung Ventilation in Non-intubated Vedio-assisted Thoracoscopic Operations May 2014 December 2014
NCT02145559 Completed Phase 1 A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid Tumors April 2014 July 2018
NCT02146092 Completed Phase 2 Incentive Spirometry Added to Physiotherapy to Reduce Postoperative Pulmonary Complications After Lung Surgery August 1, 2014 June 2017
NCT02149576 Completed Phase 2 Does Intense Regimented Surveillance Improve the Rates of Therapeutic Re-Intervention After Lung Cancer Surgery August 1, 2014 April 30, 2018
NCT00063219 Completed Phase 2 Study Evaluating MAC-321 in Non-small Cell Lung Cancer Refractory to Platinum-based Therapy February 2005
NCT02258958 Completed Extended Out-of-hospital Low-molecular-weight Heparin Prophylaxis Against DVT and PE in Patients Undergoing Major Lung Resection January 2014 December 2014
NCT02271581 Completed Effect of Symptom Management on Inflammation and Survival in Metastatic Lung Cancer October 2014 April 19, 2019
NCT00067548 Completed Phase 2 Study Evaluating EKB-569 in Advanced Non-Small Cell Lung Cancer January 2005
NCT02309567 Completed Is There Any Relation Between Serum Anti-p53 Antibody and TLG, MTV and SUV as PET Parameters in Lung Cancer Patients? May 2014 April 2016
NCT02320123 Completed N/A End-of-Life Care for African Americans May 23, 2016 August 10, 2017
NCT04721106 Enrolling by invitation Korea Post Marketing Surveillance (PMS) Study of Vizimpro March 12, 2021 March 30, 2026
NCT04425135 Not yet recruiting Phase 2 Camrelizumab Combined With Apatinib Mesylate and Standard Chemotherapy (Pemetrixed + Carboplatin) in Patients With Tyrosine Kinase Inhibitor Failure in ALK-positive Advanced NSCLC July 2020 January 2025
NCT05904015 Not yet recruiting Phase 2 The Study of Envafolimab Combined With Concurrent Chemoradiotherapy In LS-SCLC August 1, 2023 June 30, 2027
NCT06024226 Not yet recruiting Role of MDSCs and Cancer Stem Cells and Their Cross Talks in NSCLC October 2023 October 2025
NCT05850702 Not yet recruiting Phase 4 Attenuation of the Hemodynamic Response to Double-lumen Endotracheal Intubation With Nebulized Lidocaine June 15, 2023 September 9, 2025
NCT05647330 Not yet recruiting Phase 2 Hydroxychloroquine Combined With Gemcitabine in the Treatment of Advanced Non-small Cell Lung Cancer December 15, 2022 October 1, 2025
NCT05279521 Not yet recruiting N/A The Effect of Interventional Pulmonary Rehabilitation Exercise With Advanced Lung Cancer. March 20, 2022 December 30, 2024
NCT06409416 Not yet recruiting Tumor Cell Plasticity and Aggressiveness in Human Non-small Cell Lung Cancer July 1, 2024 June 1, 2026
NCT05879354 Not yet recruiting N/A Active Cycle of Breathing Techniques on Respiratory Distress Symptom Cluster June 10, 2023 May 30, 2024
NCT05110950 Not yet recruiting N/A Endobronchial Ultrasound Needle Aspiration With and Without Suction June 1, 2022 June 26, 2024
NCT06178939 Not yet recruiting N/A Effects of Cognitive Intervention Therapy on Postoperative Delirium December 2023 October 2027
NCT05666908 Not yet recruiting N/A HFNO Improves Blood Oxygen Saturation During Asphyxia During Pulmonary Surgery With Double-lumen Endotracheal Intubation January 2023 December 2024
NCT06376084 Not yet recruiting Osimertinib With Chemotherapy as First-line Therapy for EGFR Mutation-positive NSCLC July 24, 2024 February 28, 2028
NCT05326425 Recruiting Phase 2 Lazertinib in Patients With NSCLC With Asymptomatic or Mild Symptomatic Brain Metastases After Failure of EGFR TKI. June 23, 2021 June 30, 2024
NCT06177925 Recruiting Phase 2 A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC December 10, 2023 September 30, 2026
NCT00100256 Recruiting Phase 1/Phase 2 Rhenium Re 188 P2045 in Patients With Lung Cancer Who Have Received or Refused to Receive Prior Chemotherapy January 2004 April 20, 2025
NCT02630615 Recruiting Circulating Tumor Cells (CTC) in Lung Cancer October 19, 2017 August 31, 2024
NCT05299606 Recruiting N/A POWER Study (Prospective Transbronchial Microwave + Robotic-Assisted Bronchoscopy) October 24, 2022 December 31, 2025
NCT04631770 Recruiting N/A Mediastinal Lymph Node Dissection Versus Spared Mediastinal Lymph Node Dissection in Stage I GGN NSCLC May 1, 2022 May 1, 2029
NCT02264210 Recruiting Phase 2 Icotinib for Completed Resected IB NSCLC With EGFR Mutation January 2015 December 2025
NCT05834569 Recruiting Phase 4 Impact of Maxigesic on Delirium After Minimally Invasive Lung Surgery in Elderly Patients June 15, 2023 December 31, 2025
NCT06379880 Recruiting N/A Impact on Quality of Life and Health of the CONTINUUM+ CONNECT Remote Monitoring Solution April 25, 2024 February 25, 2025
NCT05203276 Recruiting Phase 2 Envafolimab Combined With Endostar in the First-line Treatment of Advanced NSCLC March 1, 2022 June 30, 2024
NCT05693363 Recruiting N/A Perioperative Specimen Imaging Using High-resolution 18F-FDG-PET-CT During Thoracic Surgery: a Pilot Study January 1, 2024 January 31, 2025
NCT04944563 Recruiting N/A Comparison of Segmentectomy Versus Lobectomy for Non-small Cell Lung Cancer ≤ 2 cm in the Middle Third of the Lung Field July 20, 2021 December 1, 2029
NCT04577599 Recruiting N/A Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54 January 7, 2021 October 31, 2025
NCT04566432 Recruiting Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients July 1, 2020 June 30, 2024
NCT02718365 Recruiting N/A Comparison Between Wedge Resection and Segmentectomy for Ground Glass Opacity- Dominant Stage IA NSCLC December 7, 2017 December 2024
NCT06218901 Recruiting Association of Psychological Distress in Patients With Lung Cancer January 1, 2016 December 31, 2028
NCT03380468 Recruiting Phase 2/Phase 3 Adjuvant Chemotherapy for High Risk Stage I Lung Adenocarcinoma January 1, 2018 December 31, 2025
NCT05586035 Recruiting Analysis of Factors and Treatment Related to Chronic Cough After Pulmonary Resection September 2, 2021 August 30, 2023
NCT05543954 Recruiting Early Phase 1 68Ga-FAPI-RGD PET/CT Imaging in the Lung Cancer Patients September 3, 2022 December 31, 2023
NCT03046316 Recruiting N/A Local Therapy in Advanced NSCLC With Non-progressive Disease (PD) After First Line Therapy June 1, 2020 July 1, 2026
NCT05512377 Recruiting Phase 2 Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or Bladder November 25, 2022 March 25, 2027
NCT06128148 Recruiting Phase 1 Study of Oral JYP0322 in Patients With Locally Advanced or Metastatic Cancer Targeting ROS1 Molecular Fusion. May 4, 2022 December 30, 2024
NCT06004440 Recruiting Real World Registry for Use of the Ion Endoluminal System September 21, 2023 August 2027
NCT05944237 Recruiting Phase 1/Phase 2 HTL0039732 in Participants With Advanced Solid Tumours July 13, 2023 September 2026
NCT05491213 Recruiting N/A TELESCOPE- TELEhealth Shared Decision-making COaching February 14, 2023 December 31, 2027
NCT01763125 Recruiting Establishment of a Tumor Bank for Blood Samples November 2003 December 2026
NCT01585675 Recruiting Specimen Banking From Patients With Lung Cancer November 3, 2005 July 1, 2035
NCT04738487 Recruiting Phase 3 Coformulation of Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab (MK-3475) Monotherapy for Programmed Cell Death 1 Ligand 1 (PD-L1) Positive Metastatic Non-Small Cell Lung Cancer (MK-7684A-003, KEYVIBE-003) April 7, 2021 June 5, 2028
NCT01789229 Recruiting Establishment of a Tumor Bank for Tissue Samples September 2003 December 2026
NCT06237881 Recruiting Phase 1/Phase 2 A Phase 1/2 Study of KSQ-001EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate the SOCS1 Gene, in Patients With Select Advanced Solid Tumors January 31, 2024 January 1, 2029
NCT02769962 Recruiting Phase 1/Phase 2 Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer May 9, 2016 December 31, 2027
NCT02549638 Recruiting Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell Carcinoma August 2015 August 2024
NCT01580982 Recruiting Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer January 23, 2012 January 30, 2027
NCT03212404 Recruiting Phase 1 Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers September 20, 2017 December 2024
NCT04185467 Suspended N/A Lung Cancer Rehabilitation After Medical Treatment December 5, 2019 December 1, 2021
NCT04925986 Terminated Phase 2 Sitravatinib Plus Pembrolizumab in Patients With Advanced Treatment-Naïve PD-L1+ Non-Squamous NSCLC February 10, 2022 October 30, 2023
NCT00356525 Terminated Phase 2 Chemotherapy Treatment in Re-occurring Non Small Cell Lung Cancer (NSCLC) After Previous Chemotherapy and Surgical Removal of the NSCLC Tumor September 2006 April 2009
NCT00962234 Terminated Metabolism of Lipids in Advanced Cancer October 2009 October 2011
NCT00976508 Terminated Phase 1 Figitumumab Combined With Pegvisomant For Advanced Solid Tumors November 2009 October 2012
NCT01479348 Terminated Early Phase 1 Imaging Study for FdCyd and THU Cancer Treatment November 1, 2011 January 11, 2019
NCT01622621 Terminated Phase 2 Stereotactic Body Radiotherapy (SBRT) Versus Sublobar Resection for High-Risk Patients Non-Small Lung Cancer May 2012 April 25, 2017
NCT01717482 Terminated Phase 2 Metformin as a Chemoprevention Agent in Non-small Cell Lung Cancer October 2012 May 22, 2019
NCT02030444 Terminated N/A Extensive Staging in Lung Cancer August 2014 August 2018
NCT02111824 Terminated Phase 1 A Multimodality Image-guided System for Peripheral Lung Cancer Diagnosis and Therapy January 5, 2014 November 2019
NCT02117440 Terminated Functional Image and Molecular Markers to Predict Treatment Outcomes in Lung Cancer May 1, 2017 March 2, 2018
NCT02199886 Terminated Phase 1 Dose-escalation Study of BIBH 1 in Patients With Non-small Cell Lung Cancer Scheduled for Surgical Resection July 1998
NCT02277366 Terminated Role of Bronchoscopy in Early Lung Cancer Screening of High Risk Population May 2015 November 2017
NCT02673021 Terminated N/A MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s) June 8, 2016 March 13, 2020
NCT02705404 Terminated A Clinical Test for the Treatment of Multifocal Lung Cancers Using Genome Sequencing February 11, 2016 November 16, 2021
NCT02715102 Terminated Circulating Tumor DNA in Patients at High Risk for Lung Cancer June 2016 August 2017
NCT02834455 Terminated N/A Rational Approach to a Unilateral Pleural Effusion2 May 2015 December 15, 2020
NCT02839681 Terminated Phase 2 Anti-Mesothelin Antibody Drug Conjugate Anetumab Ravtansine for Mesothelin Expressing Lung Adenocarcinoma July 19, 2016 July 25, 2018
NCT02859415 Terminated Phase 1/Phase 2 Continuous 24h Intravenous Infusion of Mithramycin, an Inhibitor of Cancer Stem Cell Signaling, in People With Primary Thoracic Malignancies or Carcinomas, Sarcomas or Germ Cell Neoplasms With Pleuropulmonary Metastases August 8, 2019 December 1, 2021
NCT02900248 Terminated CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice October 2, 2017 March 29, 2019
NCT03043898 Terminated Mapping Sound Propagation Through the Human Lung for Better Diagnosis February 14, 2018 April 23, 2020
NCT03137576 Terminated N/A Erector Spinae Plane Block Versus Paravertebral Block During Non-intubated Thoracoscopic Lung Resections. February 22, 2019 November 22, 2021
NCT03272087 Terminated N/A Rational Approach to a Unilateral Pleural Effusion May 2015 December 15, 2020
NCT03666728 Terminated Phase 2 A Study of SHR-1210 in Combination With BP102 in Subjects With Non-squamous NSCLC November 30, 2018 March 11, 2020
NCT02284633 Unknown status Blood Sample Monitoring of Patients With EGFR Mutated Lung Cancer September 2014 June 10, 2020
NCT03992833 Unknown status N/A Methods of Computed Tomography Screening and Management of Lung Cancer May 1, 2017 September 2022
NCT03975504 Unknown status N/A China Lung Cancer Screening (CLUS) Study Version 2.0 August 1, 2018 July 31, 2023
NCT04159337 Unknown status NGS-based Large-panel in Targeted Drug Delivery and Immunotherapy of Lung Cancer August 30, 2019 May 31, 2022
NCT03940404 Unknown status Anlotinib Therapy in Patients With Advanced Lung Cancer. May 2019 December 2020
NCT03838588 Unknown status The Tracking Molecular Evolution for NSCLC (T-MENC) Study November 6, 2018 December 31, 2021
NCT04220268 Unknown status A Prospective Cohort of Pulmonary Ground Glass Nodules Patients With Family History. January 5, 2020 January 31, 2022
NCT03589950 Unknown status Phase 2 Anlotinib Plus Chemotherapy for Patients With Advanced Non-small Cell Lung Cancer August 1, 2018 August 1, 2021
NCT03581708 Unknown status Venous Thromboembolism in Advanced Lung Cancer July 2018 June 2022
NCT03566862 Unknown status Audio Technology To Detect Lung Cancer Earlier May 16, 2017 November 30, 2018
NCT03537378 Unknown status N/A Hybrid APC Therapy in Early Central Lung Neoplasms December 26, 2018 December 30, 2019
NCT04270799 Unknown status Lung Nodule Imaging Biobank for Radiomics and AI Research June 1, 2020 August 2021
NCT03402048 Unknown status Phase 3 The EPIC Trial The Elderly Patient Individualized Chemotherapy Trial July 2012 May 2021
NCT04309955 Unknown status N/A Modified Versus Traditional Thoracic Drainage After Thoracoscopic Surgery December 1, 2019 April 1, 2020
NCT03357094 Unknown status Pulmonary Ventilation/Perfusion Imaging for the Prediction of Postoperative Residual Pulmonary Function September 30, 2017 November 1, 2019
NCT04369872 Unknown status Phase 1/Phase 2 Microwave Ablation of Primary and Secondary Lung Malignancies May 1, 2020 December 31, 2022
NCT03162705 Unknown status Molecular Profiling in Small Cell Lung Cancer May 3, 2017 December 31, 2021
NCT03113318 Unknown status N/A Mediastinal Lymph Node Dissection in Conjunction With Pulmonary Metastasectomy From Colorectal Cancer October 2015 October 2022
NCT03081741 Unknown status Circulating Tumor DNA in Surgical Lung Cancer Patients May 3, 2017 March 18, 2020
NCT04447482 Unknown status N/A ENB Vs. Conventional Bronchoscopy With Fluoroscopy for Safe and Effective Biopsy of Pulmonary Lesions July 10, 2020 September 30, 2021
NCT04486287 Unknown status Phase 2 Sintilimab After Stereotactic Ablation Brachytherapy for Refractory Oligometastatic Non-Small Cell Lung Cancer September 1, 2020 September 1, 2023
NCT02933294 Unknown status N/A Uniportal Versus Triportal Thoracoscopic Lobectomy and Sublobectomy for Early Stage Lung Cancer May 2015 December 2020
NCT02907606 Unknown status Urinary Circulating Tumor DNA Detection in Non-small Cell Lung Cancer: a Prospective Study September 2016 August 2020
NCT04513301 Unknown status Phase 2 Efficacy and Safety of Sintilimab With or Without Radiotherapy in Patients With Recurrent or IV NSCLC (EGFR -, ALK -) After Failure of Platinum-based Chemotherapy: A Randomized,Open Labled, Phase II Clinical Study January 1, 2020 December 1, 2022
NCT04540757 Unknown status Impact on Quality of Life From Multi-modality Lung Cancer November 25, 2020 January 31, 2023
NCT02837679 Unknown status N/A Oncogeriatric Intervention and Follow-up at Home January 2016 January 2023
NCT01775943 Unknown status Efficacy of EGFR TKIs in Patients With Rare EGFR-mutated NSCLC March 2013 February 2014
NCT01687647 Unknown status Phase 3 Sputum Cytometry Analysis in Lung Cancer Screening After Professional Asbestos Exposure September 2012 December 2019
NCT01527461 Unknown status Identifying Unique Scent Signature of Lung Cancer Through Body Odor February 2012
NCT00657423 Unknown status Phase 3 Impact of Endostar Combined With Chemotherapy on the Angiogenesis of Advanced Non-small Cell Lung Cancer (NSCLC) April 2008 April 2009
NCT00563160 Unknown status Phase 2 Study of Efficacy of Induction Chemotherapy With Gemcitabine and Carboplatin for Operable Non-small-cell Lung Cancer Before Surgery May 2005 February 2007
NCT00415337 Unknown status Endobronchial Ultrasound Guided Transbronchial Lung Biopsy With or Without Guide Sheath in Lung Tumors and the Analysis of Echoic Patterns of Lung Tumors and Mediastinal Lymph Nodes, and the Association Between Diagnostic Yield of Transbronchial Lung Biopsy and EBUS Echoic Features. April 2007
NCT00385164 Unknown status The Utility of FDG-PET for Radiation Treatment in NSCLC October 2006
NCT00339586 Unknown status Phase 2 First-Line EGFR-1 Tyrosine Kinase Inhibition in Patients With NSCLC With Mutant EGFR Gene January 2006
NCT00172575 Unknown status Differentiation of Malig. & Ben. Solitary Pulm. Nodules & Prediction of Clin. Outcome Using Perfus. Analysis of DCEMRI December 2004 December 2006
NCT00040560 Unknown status Phase 1 Study of 111In-DAC as an Medical Imaging Agent for Lung Cancer and Brain Cancer Consistent With Metastatic Lung Cancer
NCT02825095 Unknown status Early Phase 1 Management of Malignant Pleural Effusion - Indwelling Pleural Catheter or Talc Pleurodesis August 2016 August 2017
NCT02804100 Unknown status Dynamic Changes of Circulating Tumor DNA in Late Stage NSCLC Patients May 2016 June 2018
NCT02790190 Unknown status Phase 3 Individualized Adaptive Radiotherapy Based on PET/CT and IMRT for Locally Advanced Non-Small Cell Lung Cancer (NSCLC) May 2015 December 2017
NCT02765620 Unknown status PERCIST Criteria for Response Evaluation With Solid Tumors April 2016 April 2018
NCT04775901 Unknown status N/A Application of Three-Dimensionally Printed Navigational Template in Lung Biopsy November 25, 2020 December 31, 2023
NCT02740400 Unknown status N/A A Comparison Between EBUS-GS and CT-guided Lung Biopsy in Diagnosis of Peripheral Pulmonary Lesions. April 2015 May 2017
NCT04922073 Unknown status Practical Usability of EGFR Mutation Detection in ctDNA From Resectable NSCLC June 1, 2021 March 31, 2022
NCT02701231 Unknown status N/A Low-frequency Rotating Magnetic System Combined With Systemic Anti-tumor Therapy for Advanced Lung Cancer November 2015 December 2020
NCT02696525 Unknown status Circulating Tumor DNA Detection in Surveillance of Surgical Lung Cancer Patients December 2018 December 2021
NCT02688036 Unknown status Phase 3 Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LD-SCLC February 2016 May 2020
NCT05121233 Unknown status Phase 4 Local Anesthesia Versus Combined Local Anesthesia With Single Dose Analgesia on Pain Control During Thoracic Ultrasound Guided Procedures November 2021 October 2022
NCT05202249 Unknown status N/A Effect of Muscle and Skin Fixation of Thoracic Drainage Tube on Postoperative Pain November 15, 2021 May 15, 2022
NCT02675088 Unknown status N/A Comparable Study of Different Thoracic Radiotherapy Regimens for Extensive Stage Small Cell Lung Cancer December 1, 2017 December 2019
NCT02666755 Unknown status Novel Detection System for Lung Cancer Curative Effect Monitoring January 2016 April 2018
NCT02607605 Unknown status A Prospective, Observational Trial on the Diagnostic and Prognostic of LM August 2015 August 2020
NCT05346380 Unknown status Phase 1/Phase 2 Near-Infrared Perfusion During Minimally Invasive Thoracic Surgery Download October 29, 2020 March 1, 2023
NCT02577393 Unknown status Phase 2 Study of Epigallocatechin-3-gallate (EGCG) for Esophagus Protection in Patients With Lung Cancer Receiving Radial Radiotherapy April 2015 August 2022
NCT02518802 Unknown status Phase 3 Pemetrexed Combined With Synchronous Gefitinib as Adjuvent Therapy in Patient With EGFR Mutant Lung Adenocarcinoma January 2015 January 2020
NCT02484872 Unknown status Has Inflammation a Significant Implication in Lung Cancer Evolution? May 2015 December 2023
NCT02469493 Unknown status N/A The Effect and Mechanism of Electroacupuncture on Acute Chemotherapy-induced Nausea and Vomiting January 2015
NCT02431962 Unknown status N/A Alberta Lung Cancer Screening Program April 2015 December 2022
NCT02393664 Unknown status Phase 2/Phase 3 Effects of Nonintubated Versus Intubated General Anesthesia on Recovery After Thoracoscopic Lung Resection March 2015 October 2016
NCT02320617 Unknown status N/A Application of Diffusion Weighted MRI Versus CT in Evaluation of the Effect of Treating Lung Cancer December 2014 February 2016
NCT03988322 Unknown status N/A Computed Tomography Screening for Early Lung Cancer, COPD and Cardiovascular Disease in Shanghai, China September 1, 2018 September 2022
NCT02268162 Unknown status N/A Diagnosis of Individuals With Pulmonary Nodules by Different Bronchoscopy Combination April 2015 November 2017
NCT02157857 Unknown status One Step Nucleic Acid Amplification in Endobronchial Ultrasound-guided Needle Aspiration Samples February 2014 July 2014
NCT02835066 Withdrawn Patient Function/Fitness and Psychosocial Health in Improving Health-Related Quality of Life in Patients With Stage I-IV Non-Small Cell Lung Cancer July 2016 July 2018
NCT00090701 Withdrawn Phase 2 A Phase 2, Open-Label, Multicenter Study of the GARFT Inhibitor in Patients With Metastatic Non-Small Cell Lung Cancer September 2004
NCT05426213 Withdrawn N/A A Study of Robot-Assisted Bronchoscopy in Chinese Participants With Lung Lesions July 12, 2022 September 30, 2024
NCT01684696 Withdrawn N/A Virtual Intervention for Lung Cancer August 2016 September 2017
NCT01679743 Withdrawn Phase 2 GRN1005 for Brain Metastases From Breast or Lung Cancer August 29, 2012 August 11, 2014
NCT02264236 Withdrawn Phase 1/Phase 2 Vaccination of Advanced-Stage Lung Cancer Patients October 2015 June 2021
NCT02640326 Withdrawn N/A McMaster Catheterization for Thoracoscopic Surgery Study December 1, 2018 December 1, 2018
NCT02639234 Withdrawn Phase 2 Vigil™ + Nivolumab in Advanced Non-Small Cell Lung Cancer March 2016 March 2017
NCT00184288 Withdrawn Proton MR Spectroscopy of Brain Metastases in Evaluation of Treatment Response. November 2004 December 2010
NCT00768131 Withdrawn Phase 2 A Study to Determine Whether EGFR Status by FISH Can Predict Results in Non Small Cell Lung Cancer (NSCLC) Patients Treated With Cetuximab, Carboplatin and Paclitaxel October 2008 October 2008
MeSH unique ID (MeSH (Medical Subject Headings))
D008175